CSIMarket
 


Alpine Immune Sciences Inc   (ALPN)
Other Ticker:  
 
 

ALPN's Revenue Growth by Quarter and Year

Alpine Immune Sciences Inc 's Revenue results by quarter and year




ALPN Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter December - 30.85 2.78 4.42
III Quarter September - 10.04 8.37 8.52
II Quarter June - 8.59 5.29 7.24
I Quarter March 7.03 9.39 13.63 3.27
FY   7.03 58.87 30.07 23.45



ALPN Revenue first quarter 2024 Y/Y Growth Comment
Alpine Immune Sciences Inc reported fall in Revenue in the first quarter 2024 by -25.11% to $ 7.03 millions, from the same quarter in 2023.
The drop in the first quarter 2024 Alpine Immune Sciences Inc 's Revenue compares unfavorably to the Company's average Revenue doubling of 196.42%.

Looking into first quarter 2024 results within Major Pharmaceutical Preparations industry 131 other companies have achieved higher Revenue growth. While Alpine Immune Sciences Inc ' s Revenue drop of -25.11% ranks overall at the positon no. 2710 in the first quarter 2024.




ALPN Revenue ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter December - 1009.71 % -37.1 % -21.49 %
III Quarter September - 19.95 % -1.76 % 343.75 %
II Quarter June - 62.38 % -26.93 % 949.28 %
I Quarter March -25.11 % -31.11 % 316.82 % 200 %
FY   - 95.78 % 28.23 % 151.34 %

Financial Statements
Alpine Immune Sciences Inc 's first quarter 2024 Revenue $ 7.03 millions ALPN's Income Statement
Alpine Immune Sciences Inc 's first quarter 2023 Revenue $ 9.39 millions Quarterly ALPN's Income Statement
New: More ALPN's historic Revenue Growth >>


ALPN Revenue (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter December - 207.27 % -66.79 % -48.12 %
III Quarter September - 16.88 % 58.22 % 17.68 %
II Quarter June - -8.52 % -61.19 % 121.41 %
I Quarter March -77.21 % 237.77 % 208.37 % -41.92 %
FY (Year on Year)   - 95.78 % 28.23 % 151.34 %




Revenue first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #132
Healthcare Sector #367
Overall #2710

Revenue Y/Y Growth Statistics
High Average Low
1011.42 % 196.42 % -100 %
(Dec 31 2023)   (Mar 31 2019)
Revenue first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #132
Healthcare Sector #367
Overall #2710
Revenue Y/Y Growth Statistics
High Average Low
1011.42 % 196.42 % -100 %
(Dec 31 2023)   (Mar 31 2019)

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Alpine Immune Sciences Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
238.15 % 47.81 % -100 %
(Mar 31 2023)  


ALPN's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2024 Alpine Immune Sciences Inc realized fall in Revenue from the previous quarter by -77.21% to $ 7.03 millions, from $ 30.85 millions released in the previous reporting period.

Some seasonal influence that commonly energize I. Quarter 2024 performance, have not rescue the I. Quarter for the Alpine Immune Sciences Inc , Ludvig Karlsson, a business expert pointed out.

Within Major Pharmaceutical Preparations industry 96 other companies have achieved higher Revenue quarter on quarter growth. While Alpine Immune Sciences Inc 's Revenue growth quarter on quarter, overall rank is 2051.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #97
Healthcare Sector #263
Overall #2051
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #97
Healthcare Sector #263
Overall #2051
Revenue Q/Q Growth Statistics
High Average Low
238.15 % 47.81 % -100 %
(Mar 31 2023)  


ALPN's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2024 Alpine Immune Sciences Inc realized fall in Revenue sequentially by -77.21% to $ 7.03 millions, from $ 30.85 millions achived in the previous reporting period.

Albeit cyclical influence which usually elevate I. Quarter 2024 Revenue, it plainly could not be sufficient to recover ALPN's I. Quarter 2024 outcome, Ludvig Karlsson, a business expert wrote and mentioned that average sequential Revenue growth is at 47.81% for ALPN.

Within Major Pharmaceutical Preparations industry 96 other companies have achieved higher Revenue quarter on quarter growth. While Alpine Immune Sciences Inc 's Revenue growth quarter on quarter, overall rank is 2051.


Alpine Immune Sciences Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2024)
12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
Cumulative Revenue 12 Months Ending $ 56.52 $ 58.88 $ 30.80 $ 29.12 $ 25.82
Y / Y Revenue Growth (TTM) 118.89 % 95.84 % -2.85 % -8.57 % -23.61 %
Year on Year Revenue Growth Overall Ranking # 2494 # 303 # 511 # 345 # 128
Seqeuential Revenue Change (TTM) -4 % 91.16 % 5.75 % 12.78 % -14.11 %
Seq. Revenue Growth (TTM) Overall Ranking # 1588 # 1743 # 1924 # 2814 # 530




Cumulative Revenue growth Comment
Although Alpine Immune Sciences Inc 's Annual Revenue growth year on year were below company's average 147.22% , Revenue announced in the Mar 31 2024 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 118.89% year on year, from 95.84% in Dec 31 2023.

In the Healthcare sector 334 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 303 to 2494.

Revenue TTM Q/Q Growth Statistics
High Average Low
512.03 %
147.22 %
-23.61 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 74
Healthcare Sector # 335
Overall # 2494

Revenue TTM Y/Y Growth Statistics
High Average Low
512.03 %
147.22 %
-23.61 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 74
Sector # 210
S&P 500 # 1588
Cumulative Revenue growth Comment
Although Alpine Immune Sciences Inc 's Annual Revenue growth year on year were below company's average 147.22% , Revenue announced in the Mar 31 2024 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 118.89% year on year, from 95.84% in Dec 31 2023.

In the Healthcare sector 334 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 303 to 2494.

Revenue TTM Q/Q Growth Statistics
High Average Low
512.03 %
147.22 %
-23.61 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 74
Healthcare Sector # 335
Overall # 2494

Revenue TTM Y/Y Growth Statistics
High Average Low
512.03 %
147.22 %
-23.61 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 74
Sector # 210
S&P 500 # 1588




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ALPN's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for ALPN's Competitors
Revenue Growth for Alpine Immune Sciences Inc 's Suppliers
Revenue Growth for ALPN's Customers

You may also want to know
ALPN's Annual Growth Rates ALPN's Profitability Ratios ALPN's Asset Turnover Ratio ALPN's Dividend Growth
ALPN's Roe ALPN's Valuation Ratios ALPN's Financial Strength Ratios ALPN's Dividend Payout Ratio
ALPN's Roa ALPN's Inventory Turnover Ratio ALPN's Growth Rates ALPN's Dividend Comparisons



Companies with similar Revenue fall for the quarter ending Mar 31 2024 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2024
Collegium Pharmaceutical inc -0.21%$ -0.215 millions
Mettler Toledo International Inc-0.30%$ -0.300 millions
3m Company-0.35%$ -0.349 millions
Icu Medical Inc-0.42%$ -0.423 millions
Lifeloc Technologies Inc -0.51%$ -0.513 millions
Regeneron Pharmaceuticals Inc -0.54%$ -0.541 millions
Envista Holdings Corporation-0.62%$ -0.622 millions
Orgenesis Inc -0.70%$ -0.704 millions
Vyne Therapeutics Inc -1.01%$ -1.010 millions
Ge Healthcare Technologies Inc -1.50%$ -1.502 millions
Baxter International Inc -1.56%$ -1.562 millions
Y mabs Therapeutics inc -1.58%$ -1.580 millions
Pacific Biosciences Of California Inc -1.59%$ -1.589 millions
Cartesian Therapeutics Inc -1.65%$ -1.650 millions
Viatris Inc -1.76%$ -1.762 millions
Ocuphire Pharma Inc -2.17%$ -2.173 millions
Vaso Corporation-2.51%$ -2.513 millions
Dentsply Sirona Inc -2.56%$ -2.556 millions
Alpha Pro Tech Ltd -2.78%$ -2.775 millions
Prestige Consumer Healthcare Inc -2.82%$ -2.817 millions
West Pharmaceutical Services Inc -2.99%$ -2.986 millions
Integra Lifesciences Holdings Corp-3.14%$ -3.144 millions
Accelerate Diagnostics Inc -3.17%$ -3.165 millions
National Research Corporation-3.18%$ -3.180 millions
Catheter Precision Inc -3.53%$ -3.529 millions
Elanco Animal Health Inc-4.14%$ -4.137 millions
Ptc Therapeutics inc -4.66%$ -4.657 millions
Foghorn Therapeutics Inc -4.88%$ -4.879 millions
Aclaris Therapeutics Inc -5.14%$ -5.142 millions
Avantor Inc -5.65%$ -5.645 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com